Precision strategies to eradicate heterogeneous tumor cells in pediatric cancer – Kasper Karlsson's Group

Our research focuses on improving cure rates for children with neuroblastoma and rhabdomyosarcoma. Specifically, we are interested in methods to overcome tumor heterogeneity, e.g., by molecular radiotherapy and “Precision Lethality”, a concept that we have developed. We frequently use methods such as organoids, expressed cell barcoding, single cell sequencing and high-throughput drug screening.